广康生化
(300804)
| 流通市值：5.14亿 | | | 总市值：21.17亿 |
| 流通股本：1794.88万 | | | 总股本：7400.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 178,058,819.17 | 495,011,431.63 | 356,117,455.91 | 262,431,524.62 |
| 营业收入 | 178,058,819.17 | 495,011,431.63 | 356,117,455.91 | 262,431,524.62 |
| 二、营业总成本 | 155,892,855.08 | 465,892,744.65 | 332,409,611.52 | 229,711,754.68 |
| 营业成本 | 133,674,766.36 | 376,060,219.89 | 272,438,103.84 | 189,870,109.72 |
| 税金及附加 | 391,655.34 | 1,402,211.59 | 933,398.73 | 611,150.62 |
| 销售费用 | 2,057,426.67 | 6,086,963.91 | 4,283,864.67 | 3,130,337.08 |
| 管理费用 | 13,994,971.17 | 47,513,451.1 | 33,202,061.45 | 20,313,861.23 |
| 研发费用 | 4,379,916.17 | 27,066,920.59 | 16,959,260.69 | 11,268,144.42 |
| 财务费用 | 1,394,119.37 | 7,762,977.57 | 4,592,922.14 | 4,518,151.61 |
| 其中:利息费用 | 2,266,185.83 | 7,824,658.21 | 5,532,733.82 | - |
| 其中:利息收入 | 1,293,478.5 | 2,789,810.13 | 2,353,229.79 | - |
| 加:公允价值变动收益 | - | 49,605.83 | - | - |
| 加:投资收益 | 1,570,493.95 | 4,012,707.93 | 127,191.63 | - |
| 资产处置收益 | - | 25,272.71 | 552,182.8 | - |
| 资产减值损失(新) | - | -2,233,777.17 | - | - |
| 信用减值损失(新) | -3,159,352.38 | -1,078,234.29 | 423,370.74 | -6,211.13 |
| 其他收益 | 377,908.79 | 1,222,499.95 | 932,892.85 | 643,285.75 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 20,955,014.45 | 31,116,761.94 | 25,743,482.41 | 33,356,844.56 |
| 加:营业外收入 | 6,175.02 | 2,050,371.52 | 50,371.32 | 5,810 |
| 减:营业外支出 | 438,713.09 | 2,557,706.34 | 1,757,672.75 | 1,028,370.47 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 20,522,476.38 | 30,609,427.12 | 24,036,180.98 | 32,334,284.09 |
| 减:所得税费用 | 2,884,165.12 | 538,014.01 | 3,972,308.45 | 4,075,439.56 |
| 六、净利润 | 17,638,311.26 | 30,071,413.11 | 20,063,872.53 | 28,258,844.53 |
| 持续经营净利润 | 17,638,311.26 | 30,071,413.11 | 20,063,872.53 | 28,258,844.53 |
| 归属于母公司股东的净利润 | 17,670,252.56 | 30,071,413.11 | 20,063,872.53 | 28,258,844.53 |
| 少数股东损益 | -31,941.3 | - | - | - |
| (一)基本每股收益 | 0.24 | 0.46 | 0.33 | 0.51 |
| (二)稀释每股收益 | 0.24 | 0.46 | 0.34 | 0.51 |
| 九、综合收益总额 | 17,638,311.26 | 30,071,413.11 | 20,063,872.53 | 28,258,844.53 |
| 归属于母公司股东的综合收益总额 | 17,670,252.56 | 30,071,413.11 | 20,063,872.53 | 28,258,844.53 |
| 归属于少数股东的综合收益总额 | -31,941.3 | - | - | - |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |